DIRECTORIO DE DOCUMENTOS EDITADOS EN MARZO 2010

DIRECTORIO DE DOCUMENTOS EDITADOS EN MARZO 2010

CIENCIAS MÉDICAS NEWS
CIENCIAS MÉDICAS APLICADAS
RESEARCH & CLINICAL DEVELOPMENT
http://elbiruniblogspotcom.blogspot.com
http://saludequitativa.blogspot.com
http://herenciageneticayenfermedad.blogspot.com

Consultas acumuladas desde enero 2009 a la fecha: 160.500
Discriminadas como sigue:
1. ARGENTINA: 26.529 [16,5%]
2. ESPAÑA: 26.310 [16,4%]
3. MÉXICO: 23.069 [14,4%]
4. U.S.A.: 15.403 [9,6%]
5. VENEZUELA: 9.483 [5,9%]
6. PERÚ: 9.442 [5,9%]
7. COLOMBIA: 9.414 [5,9%]
8. CHILE: 5.608 [3,5%]
9. ECUADOR: 4.055 [2,5%]
10. BOLIVIA: 2.923 [1,8%]
11. LOS DEMÁS: 28.276 [17,6%]
Total de consultas: 160.512

Documentos del mes de marzo: 497
Documentos acumulados en 2010: 1.352
ARCHIVO DEL BLOG
• ▼ 2010 (1352)
o ▼ marzo (497)
 497. A High Proportion of DNA Variants of BRCA1 and BRC...
 496. Applying the GRADE Approach: Perspective from the ...
 495. American Society of Clinical Oncology Titles
 494. Alcohol Consumption & Cancer Risk
 493. polidocanol: FDA Approves Asclera to Treat Small V...
 492. Initial Genomics of the Human Nucleolus
 491. New Genetic Testing Registry announced
 490. No More Dialysis: Immunologists Develop Method To ...
 489. What Makes You Unique? Not Genes So Much As Surrou...
 488. New Test May Allow Screening For Fragile X Syndrom...
 487. Genes May Exert Opposite Effects In Diabetes And I...
 486. Probable better genetic test for autism discovered...
 485. HIV/AIDS Update - Expanded indication for Viread, ...
 484. WUPyV in Children with Acute Respiratory Tract Inf...
 483. Influenza Virus Transmission from Horses to Dogs, ...
 482. Intestinal Capillariasis, Western Mindanao, the Ph...
 481. Standards for Securing the Drug Supply Chain - Sta...
 480. Analysis of Crude Heparin by HPLC/SAX for Oversulf...
 479. Screening for osteoporosis in the adult U.S. popul...
 478. Spinal cord injury (SCI). Evidence-based nutrition...
 477. Gestational diabetes mellitus (GDM). Evidence-base...
 476. Celiac disease (CD). Evidence-based nutrition prac...
 475. Research Suggests Food Availability Could Prompt A...
 474. Insights into Managing Type 2 Diabetes
 473. Comparing Models that Assess Breast Cancer Risk
 472. Psychopathic Traits Linked to Brain Reward System
 471. Gene Rejuvenates Mouse Embryonic Stem Cell Immorta...
 470. Q&A on Rotarix® Vaccine for Healthcare Providers a...
 469. Buruli Ulcer, Central African Republic
 468. Cholera Outbreak, Laos, 2007
 467. Bartonella spp. Infections, Thailand
 466. Clostridium difficile in Ground Meat, France
 465. Panton-Valentine Leukocidin–Positive MRSA, Shangha...
 464. 16S rRNA Methyltransferase RmtC in Salmonella ente...
 463. Pandemic (H1N1) 2009 in Breeding Turkeys, Valparai...
 462. Novel Corynebacterium diphtheriae in Domestic Cats...
 461. Porcine-Origin Gentamicin-Resistant Enterococcus f...
 460. Hypervirulent Clostridium difficile Strains in Hos...
 459. Fluoroquinolone Resistance and Clostridium diffici...
 458. Innovative Uses for Syndromic Surveillance
 457. Escherichia albertii in Wild and Domestic Birds
 456. Phylogenetic Analysis of Enterohemorrhagic Escheri...
 455. Clostridium difficile Infections among Hospitalize...
 454. human rotavirus, live attenuated / EPARs for human...
 453. Livestock-associated Methicillin-Resistant Staphyl...
 452. Denialism: How Irrational Thinking Hinders Scienti...
 451. Buruli Ulcer Lesions in HIV-Positive Patient
 450. Public Health Agencies Warn of Outbreaks Related t...
 449. New diabetes figures in China: IDF press statement...
 448. Contribution of Streptococcus anginosus to Infecti...
 447. Plasmodium knowlesi in Human, Indonesian Borneo
 446. Factors Influencing Emerging Infectious Diseases i...
 445. Enabling Patient-Centered Care through Health Info...
 444. Community-associated Methicillin-Resistant Staphyl...
 443. COMMUNICATIONS, EDUCATION, AND BEHAVIORAL STUDIES ...
 442. Aberration Detection Updates 16th Semiannual Meeti...
 441. 2009 H1N1 Influenza Vaccine with Long-Dated Expira...
 440. 2009 Pandemic Influenza A (H1N1) in Pregnant Women...
 439. Rapid Antigen Test for Pandemic (H1N1) 2009 Virus
 438. Possible transmission of pandemic (HIN1) 2009 viru...
 437. 1918 and 2009 Pandemic Influenza Viruses Lack a Su...
 436. Rapid Development of Drug-Resistant 2009 H1N1 Infl...
 435. Public Health Agencies Collaborate to Prevent Furt...
 434. Pandemic (H1N1) 2009 - update 93
 433. User Fee Billable Biologic Products and Potencies ...
 432. Mechanisms of Chromosomal Instability
 431. Prostate Cancer Genes Associated With TMPRSS2-ERG ...
 430. Risk Of A Second Breast Cancer May Be Increased By...
 429. Testing common genetic variants for breast cancer ...
 428. Clinical utility of gene expression profiling in l...
 427. New Theory Of Down Syndrome May Lead To New Therap...
 426. Researchers Identify 2 Genes Linked to Fatty Liver...
 425. Genes associated with blood clotting
 424. Study Links Genetic Variation To Possible Protecti...
 423. Study finds genes that keep watch on blood clottin...
 422. Tick-Borne Encephalitis Among U.S. Travelers to Eu...
 421. Racial and Ethnic Differences in Breastfeeding Ini...
 420. 2009 Pandemic Influenza A (H1N1) in Pregnant Women...
 419. rifaximin: FDA Approves New Use of Xifaxan for Pat...
 418. Diet Quality Worsens as Alcohol Intake Increases
 417. lacosamide - EPARs for human use
 416. degarelix - EPARs for human use
 415. Olanzapine - EPARs for human use
 414. Updated Exercise and Physical Activity Tips for Ol...
 413. Statement of Christine F. Sizemore, Ph.D. and Anth...
 412. 1918 and 2009 Pandemic Influenza Viruses Lack a Su...
 411. Shaping systems for better behavioral choices: les...
 410. Medical, Statistical, and Clinical Pharmacology Re...
 409. clopidogrel - EPARs for human use
 408. Insulin human (rDNA) - EPARs for human use
 407. Recently Updated Advisory Committee Materials
 406. NCCN Resource Tool: Risk Evaluation & Mitigation S...
 405. Recently Updated Advisory Committee Material
 404. Todo sobre la campaña de vacunación 2010 (Influenz...
 403. Urinary tract infections in renal insufficiency, t...
 402. Urinary tract infections in children. In: Guidelin...
 401. Urethritis. In: Guidelines on urological infection...
 400. Uncomplicated urinary tract infections in adults. ...
 399. Specific infections. In: Guidelines on urological ...
 398. Sexually transmitted infections. In: Guidelines on...
 397. Sepsis syndrome in urology (urosepsis). In: Guidel...
 396. Prostatitis and chronic pelvic pain syndrome. In: ...
 395. Peri-operative antibacterial prophylaxis in urolog...
 394. Epididymitis and orchitis. In: Guidelines on urolo...
 393. Complicated urinary tract infections due to urolog...
 392. Catheter-associated urinary tract infections. In: ...
 391. Nuevo enfoque en la lucha contra la tuberculosis
 390. Estudio para acelerar el lanzamiento de cinco fárm...
 389. C. DIFFICILE, NOSOCOMIAL, DESPLAZAMIENTO DE SARM -...
 388. INFLUENZA, H1N1, MUERTE DE PACIENTE - HONDURAS
 387. VIH/SIDA, CIRCUNCISIÓN, NO PREVENTIVA EN HOMOSEXUA...
 386. VACUNA DE ROTAVIRUS, CONTAMINACIÓN, CIRCOVIRUS - E...
 385. LEISHMANIASIS TEGUMENTARIA, BROTE - VENEZUELA (MIR...
 384. SARM, MENOR RIESGO DE INFECIÓN, BAÑOS CON CLORHEXI...
 383. Dosage and Administration Section of Labeling for ...
 382. Irritable Bowel Syndrome — Clinical Evaluation of ...
 381. Patient safety research: an overview of the global...
 380. Medication Errors with the Dosing of Insulin: Prob...
 379. Genetically-Defined Deficiency of Mannose-Binding ...
 378. 2010 Immunization News
 377. Urinary Incontinence
 376. Diagnosis and Management of Primary Sclerosing Cho...
 375. ASSESSMENT AND MANAGEMENT OF URINARY INCONTINENCE ...
 374. Resting May Boost Memory
 373. How Mosquitos Get a Whiff of Humans
 372. Gene Linked to Food Allergy-Related Disorder
 371. Withdrawals of Application - Medicinal Products fo...
 370. Human Medicines - CHMP Summaries of Opinion
 369. Recombinant coagulation Factor IX - EPARs for huma...
 368. Temozolomide - EPARs for human use
 367. moroctocog alfa - EPARs for human use
 366. vildagliptin / metformin hydrochloride [2] - EPARs...
 365. vicandra / metformin hydrochloride - EPARs for hum...
 364. gefitinib - EPARs for human use
 363. vildagliptin / metaformin hydrochloride - EPARs fo...
 362. HIV/AIDS Update - Upcoming FDA Advisory Committee ...
 361. Fatalities Reported to FDA Following Blood Collect...
 360. Rotarix Vaccine: Recommendation to suspend use-Pre...
 359. How Junk DNA Affects Heart Disease
 358. Gut Bacteria May Influence Metabolic Syndrome
 357. First Genes Tied to Stuttering
 356. Best Treatment Differs for Kids With Asthma
 355. Mosquito Defense Mechanism Protects Malaria Parasi...
 354. Whole-Genome Analyses Pinpoint Disease Genes in Fa...
 353. Insights into Managing Type 2 Diabetes
 352. A Clinical Perspective of Autoinflammatory Disease...
 351. National Vaccine Advisory Committee (NVAC) Meeting...
 350. Drug Information Update- FDA Drug Info: Drug Safet...
 349. Immunization Schedules by CDC
 348. Components of Extraneous Virus Detected in Rotarix...
 347. Women´s BodyWorks Evaluation Final Report
 346. How do I report a problem with an FDA-regulated pr...
 345. Changes In Muscle Cell Structure Can Affect Gene E...
 344. New statistical method for genetic studies
 343. Database to Fill Information Gaps and Serve as Res...
 342. Level of Gene Alters Risk of Alzheimer's Disease, ...
 341. Chromosome linked to diabetics’ heart risks
 340. Genetic Testing for Cancer Risk Not Clinically Use...
 339. CDC and the Arthritis Foundation Launch the 1st Na...
 329. Sources of potential systemic lupus erythematosus
 328. Marketing Authorisation (MA) Withdrawals and Suspe...
 327. Effects of lifestyle and exposures are mirrored in...
 326. First whole-genome sequencing for rare genetic dis...
 325. Sequencing Genome Of Entire Family Reveals Parents...
 324. Family history is strong predictor of obstructive ...
 323. Research Team Identifies Genes Linked To Ulcerativ...
 322. Asian cancer genomic research initiative
 321. Science Report - Revista Digital de CEDEPAP TV - ...
 320. Gene Expression-Based Prognostic Signatures In Lun...
 319. Subsidios para Investigación Médica
 318. Hereditary Condition Causing Limb Weakness Traced ...
 317. Bench to Bassinet Program Seeks Congenital Heart D...
 316. A better genetic test for autism
 315. Autism Consortium study in Pediatrics shows CMA fi...
 314. Human Medicines - CHMP Opinions on Referrals
 313. Human Medicines - CHMP Summaries of Opinion
 312. Recently Updated Advisory Committee Materials
 311. Tissue Reference Group
 310. Triplet births - trends in mortality and care
 309. simvastatin: increased risk of muscle injury with ...
 308. Drug Information Update - FDA Warns about Increase...
 307. DENGUE, AUMENTO MARCADO DE CASOS - ECUADOR
 306. INFLUENZA, H1N1, REAPARICIÓN - PERÚ (TRUJILLO)
 305. DENGUE, CONSTRUCCIONES DE INMUEBLES, AUMENTO DE CA...
 304. TUBERCULOSIS, MULTIDROGORESISTENTE, CASOS, MUERTES...
 303. TUBERCULOSIS, AUMENTO MARCADO - REINO UNIDO [ISID/...
 302. Grupo Canadá pide acción por "catastrófica" tasa t...
 301. Manual de Alergia a los Medicamentos [un documento...
 300. Recently Updated Advisory Committee Materials
 299. Health Literacy Research Funding Opportunities
 298. carglumic acid: to treat a condition that results ...
 297. NHGRI Launches Genomic Careers Resource for Studen...
 296. NIH Announces Genetic Testing Registry
 295. Adding Common Genetic Variants to Breast Cancer Ri...
 294. World Water Day --- March 22, 2010
 293. Use of a Reduced (4-Dose) Vaccine Schedule for Pos...
 292. Notice to Readers: Additional Information Regardin...
 291. Launch of TB Genotyping Information Management Sys...
 290. Announcements: Release of Issue Brief: Unintention...
 289. Investigational Heptavalent Botulinum Antitoxin (H...
 288. Monitoring Tuberculosis Programs --- National Tube...
 287. Decrease in Reported Tuberculosis Cases --- United...
 286. World TB Day
 285. Unintentional Drug Poisoning: News from CDC's Inju...
 284. Pharmacokinetics in Patients with Impaired Renal F...
 283. Treatment and Recommendations for Homeless Patient...
 282. VACCINES TO PREVENT HUMAN PAPILLOMAVIRUS update
 281. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES VACCI...
 280. Human medicines - Orphan medicinal products
 279. aztreonam - EPARs for human use
 278. The 1999–2006 United States Cancer Statistics (USC...
 277. NIH Clinical Center to Open State-of-the-Art Pharm...
 276. One Flu for One Health
 275. Patients with Pandemic (H1N1) 2009 in Intensive Ca...
 274. Risk for Transmission of Pandemic (H1N1) 2009 Viru...
 273. Morbid Obesity as a Risk Factor for Hospitalizatio...
 272. Factors Associated With Death or Hospitalization D...
 271. Critical Care Services and 2009 H1N1 Influenza in ...
 270. Critically Ill Patients With 2009 Influenza A(H1N1...
 269. Morbid Obesity as a Risk Factor for Hospitalizatio...
 268. The Risk Communicator by CDC
 267. FDA Update on the Investigation into the Salmonell...
 266. WHO guidelines for pharmacological management of p...
 265. SCREENING FOR CERVICAL CANCER
 264. Management of antithrombotic agents for endoscopic...
 263. Screening for depression in adults
 262. Mumps Outbreaks by CDC
 261. Evidence-Based Practices: Shaping Mental Health Se...
 260. Evidence-Based Practices: Shaping Mental Health Se...
 259. Evidence-Based Practices: Shaping Mental Health [3...
 258. Evidence-Based Practices: Shaping Mental Health Se...
 257. Evidence-Based Practices: Shaping Mental Health Se...
 256. Sodium oxybate - EPARs for human use
 255. Questions and Answers for Consumers about FDA's Ac...
 254. Melanoma Transcriptome Reveals Novel Genomic Alter...
 253. Genetic health risks in children of assisted repro...
 252. Gene May Be Among Most Influential Factors in Down...
 251. Genetic factors and cardiovascular risk prediction...
 250. Screening Cancer Genomes for the Driver Mutations ...
 249. Targeting Leukaemia Cell's Gene 'addiction' Presen...
 248. Knowing Your Colon Cancer Family History Could Sav...
 247. Comparative Effectiveness of Angiotensin Convertin...
 246. Breast cancer genome study launching
 245. Mitochondrial genetic heterogeneity in normal and ...
 244. Improvements Needed In Genomic Test Result Discuss...
 243. Clinical Genetic Testing for Patients With Autism ...
 242. Stem cell transplantation in adults: recommendatio...
 241. National Institutes of Health Consensus Developmen...
 240. Identification and management of familial hypercho...
 239. Attention deficit hyperactivity disorder. Diagnosi...
 238. Stroke. Diagnosis and initial management of acute ...
 237. Metastatic spinal cord compression. Diagnosis and ...
 236. Cervical cytology screening / American College of ...
 235. Patients Who Take a Proton-Pump Inhibitor with Med...
 234. 2009-2010 Influenza Season Week 9 ending March 6, ...
 233. Pandemic (H1N1) 2009 - update 91
 232. Statement to Healthcare Professionals on the ACCOR...
 231. First Inherited Prostate Cancer Genetic Mutation F...
 230. In U.S. Imaging First, Prenatal MRI Detects Rare G...
 229. Researchers Identify Previously Unrecognized Genet...
 228. Studies On Nutrients And Gene Expression Could Lea...
 227. How the human genome folds in 3-D
 226. Low Tolerance for Pain May Be Genetic
 225. The molecular genetic basis of ovarian cancer and ...
 224. 1-2-year Surveillance Intervals Reduce Risk of Col...
 223. Surveillance Lessons from First-wave Pandemic (H1N...
 222. Neurologic Manifestations of Pandemic (H1N1) 2009 ...
 221. Rhabdomyolysis and Pandemic (H1N1) 2009 Pneumonia ...
 220. Rare Influenza A (H3N2) Variants with Reduced Sens...
 219. besilesomab - EPARs for human use - Technetium (99...
 218. Withdrawals of Application - Medicinal Products fo...
 217. Finding Charcot-Marie-Tooth gene ends a quest and ...
 216. Genetic cause discovered for rare bleeding disorde...
 215. Disease Cause Is Pinpointed With Genome
 214. A fingerprint for genes
 213. Mathematical innovation turns blood draw into info...
 212. New Approach to Immune Cell Analysis Seen as First...
 211. Food Allergy-Related Disorder Linked to Master All...
 210. A Deep Look Into Population Variation In Gene Acti...
 209. Lynch Syndrome EGAPP Recommendation
 208. Focus on Heart Health
 207. DENGUE, EPIDEMIA: ACTUALIZACIÓN - PARAGUAY
 206. DENGUE, REINTRODUCCIÓN - ECUADOR (GALÁPAGOS)
 205. ROTAVIRUS, DIARREAS: ALERTA EPIDEMIOLÓGICA, OPS - ...
 204. SALMONELLA TYPHI, BIOFILMS, RESERVORIO EN CÁLCULOS...
 203. Effectiveness of Recombinant Human Growth Hormone ...
 202. Recombinant Hepatitis B virus surface antigen (HBs...
 201. Measles, mumps, rubella and varicella vaccine (liv...
 200. measles, mumps and rubella vaccine (live) - EPARs ...
 199. rotavirus vaccine, live, oral - EPARs for human us...
 198. follitropin beta - EPARs for human use
 197. Notice to Providers Concerning Potential Cases of ...
 196. Vaccine Excipient & Media Summary, Part 2 Excipien...
 195. Japanese Encephalitis (3/01/10) Updated
 194. Anthrax (3/10/10) Updated
 193. The MedWatch February 2010 Drug Safety Labeling Ch...
 192. Agency for Healthcare Research and Quality (AHRQ) ...
 191. Market Withdrawal of Chiron RIBA HCV 3.0 SIA
 190. WITHDRAWAL ASSESSMENT REPORT FOR ONCOPHAGE
 189. Questions and answers on the recommendation for th...
 188. Nitisinone - EPARs for human use
 187. Thyrotropin alfa - EPARs for human use
 186. HIV/AIDS Update - Intelence (etravirine) label rev...
 185. Medicines for children [update march 12, 2010] II/...
 184. Medicines for children [update march 12, 2010] I/I...
 183. Invasive Pneumococcal Disease in Young Children Be...
 182. Counterfeit Polypropylene Surgical Mesh: Counterfe...
 181. AUTISM update
 180. clopidogrel: Reduced effectiveness in patients who...
 179. Licensure of a 13-Valent Pneumococcal Conjugate Va...
 178. FDA Hepatitis Update - Follow-up about planned FDA...
 177. FDA Drug Safety Communication: Ongoing safety revi...
 176. NIAID Media Availability: Vaccinating Children aga...
 175. Japanese Encephalitis Vaccines
 174. Licensure of a Meningococcal Conjugate Vaccine (Me...
 173. Progress Toward Poliomyelitis Eradication --- Afgh...
 172. Short-Term Effects of Health-Care Coverage Legisla...
 171. Licensure of a 13-Valent Pneumococcal Conjugate Va...
 170. Invasive Pneumococcal Disease in Young Children Be...
 169. Meningococcal Outbreak, Greater Aachen Region, Ger...
 168. Effects of Mumps Outbreak in Hospital | CDC EID
 167. Are Patient-Held Vaccination Records Associated Wi...
 166. Vaccines: Events/NIIW/2010 Activities
 165. Stroke rehabilitation [5/5] and community reintegr...
 164. Stroke rehabilitation [4/5] and community reintegr...
 163. Stroke rehabilitation [3/5] and community reintegr...
 162. Stroke rehabilitation [2/5] and community reintegr...
 161. Stroke rehabilitation [1/5] and community reintegr...
 160. Vaginal Birth After Cesarean: New Insights: Struct...
 159. potential expanded access programs with direct-act...
 158. NEJM -- Use of the Thyroid Hormone Analogue Eproti...
 157. DÍA MUNDIAL DEL RIÑÓN: 11 de marzo de 2010 - Intra...
 156. DIA MUNDIAL DEL RIÑÓN: 11 de marzo de 2010 / Intra...
 155. febuxostat - EPARs for authorised medicinal produc...
 154. SCREENING FOR LIPID DISORDERS IN ADULTS - NGC - Co...
 153. Selected topics in stroke management. [4/4] Vascul...
 152. Selected topics in stroke management. [3/4] Should...
 151. Selected topics in stroke management. [2/4] Identi...
 150. Selected topics in stroke management. [1/4] Dyspha...
 149. Public awareness and patient education. [2/2] Publ...
 148. Public awareness and patient education. [1/2] Pati...
 147. Prevention of stroke [7/7]. Lipid management. In: ...
 146. Prevention of stroke [6/7]. Lifestyle and risk fac...
 145. Prevention of stroke [5/7]. Diabetes management. I...
 144. Prevention of stroke [4/7]. Carotid intervention. ...
 143. Prevention of stroke [3/7]. Blood pressure managem...
 142. Prevention of stroke [2/7]. Antithrombotic therapy...
 141. Prevention of stroke. [1/7] Antiplatelet therapy. ...
 140. Vaccinating Children Against Flu Helps Protect Wid...
 139. FDA Approves Botox to Treat Spasticity in Flexor M...
 138. lapatinib tablets by FDA
 137. CDER NEWS by FDA
 136. National Children's Mental Health Awareness Day
 135. Hyperacute stroke management. Neurovascular imagin...
 134. Hyperacute stroke management. Management of subara...
 133. Hyperacute stroke management. Emergency medical se...
 132. Hyperacute stroke management. Blood glucose abnorm...
 131. Hyperacute stroke management. Acute thrombolytic t...
 130. Hyperacute stroke management. Acute management of ...
 129. Hyperacute stroke management. Acute ASA therapy. I...
 128. Acute inpatient stroke care. Components of acute i...
 127. Acute inpatient stroke care. Stroke unit care. In:...
 126. Revised American Thyroid Association Management Gu...
 125. Pharmacologic treatment of spasticity in children ...
 124. 2009-2010 Influenza Season Week 8 ending February ...
 123. WHO - Pandemic (H1N1) 2009 - update 90
 122. Chicago Journals - Clinical Infectious Diseases
 121. Human Medicines - Herbal Medicinal Products - Adop...
 120. European Medicines Agency - Human Medicines - Orph...
 119. HIDROCARBUROS AROMÁTICOS POLICÍCLICOS, CONTAMINACI...
 118. METANOL, INTOXICACIÓN, MUERTES - PERÚ (CALLAO) ISI...
 117. INFECCIONES consecuentes al terremoto - ISID / CHI...
 116. FDA Approves Therapy to Treat Gaucher Disease
 115. CDC H1N1 Flu | Q&A: Behavioral Risk Factor Surveil...
 114. Clinical and economic outcomes attributable to hea...
 113. AHRQ Patient Safety Network: Initiative to Reduce ...
 112. WHO | Pandemic (H1N1) 2009 - update 89
 111. Strontium ranelate [2] - EPARs for authorised medi...
 110. ulipristal - EPARs for authorised medicinal produc...
 109. mifamurtide - Authorised Medicines for Human Use...
 108. Strontium ranelate - EPARs for authorised medicina...
 107. FDA Expands Commitment to Patients with Rare Disea...
 106. Submission of Documentation in Applications for Pa...
 105. Adaptive Design Clinical Trials for Drugs and Biol...
 104. Inhaled Nitric Oxide in Preterm Infants
 103. Lead: Health Studies & Clinical Trials
 102. Vol. 16, No. 3 Cover: The Fleas of Fleas | CDC EID...
 101. Murine Typhus, Texas, USA | CDC EID
 100. Borrelia, Ehrlichia, and Rickettsia spp. in Ticks ...
 099. R. helvetica in Patient with Meningitis | CDC EID
 098. Spotted Fever Group Rickettsiosis, Brazil | CDC EI...
 097. Rickettsia felis, West Indies | CDC EID
 096. Rickettsia africae, Western Africa | CDC EID
 095. Rabies and Postexposure Prophylaxis | CDC EID
 094. Vaccines: Recs/Provisional/Provisional Recs main p...
 093. Baxter HomeChoice and HomeChoice PRO Automated Per...
 092. Research Activities, February 2010: Emergency Care...
 091. Research Activities, February 2010: Emergency Care...
 090. Research Activities, February 2010: Child/Adolesce...
 089. Research Activities, February 2010: Child/Adolesce...
 088. European Medicines Agency - Human Medicines - Orph...
 087. Ibandronic acid - EPARs for authorised medicinal...
 086. SafeYouth.org - Violence Prevention Topics - Girls...
 085. WHO CGMP FDA GUIDELINES PHARMACEUTICAL VALIDATION ...
 084. Facilidades para la formación en endoscopia gastro...
 083. Alerta: Exceso de exposición a la radiación en los...
 082. ¿Qué tal que usted pudiera descargar artículos de ...
 081. Anestesia: Manejo de la vía aérea ante intubación ...
 080. Aspiración de secreciones en el niño intubado
 079. Management of the PTCC Nonclinical Biologics Subco...
 078. follitropin beta - Authorised Medicines for Human ...
 077. aliskiren - EPARs for authorised medicinal produ...
 076. CDC Novel H1N1 Flu |CDC Estimates of 2009 H1N1 Inf...
 075. Immune Globulin Subcutaneous (Human), 20% Liquid -...
 074. Drug Information Update - FDA Approves Name Change...
 073. Brain Injury Awareness Month --- March 2010
 072. World Kidney Day --- March 11
 071. Announcements: Ground Water Awareness Week --- Mar...
 070. New WISQARS Fatal Injury Mapping Module
 069. Respiratory Syncytial Virus Activity --- United St...
 068. Severe Isoniazid-Associated Liver Injuries Among P...
 067. Identifying Infants with Hearing Loss --- United S...
 066. Malaria Acquired in Haiti --- 2010
 065. Medical, Statistical, and Clinical Pharmacology Re...
 064. FDA Approves First Generic Tamsulosin to Treat Enl...
 063. Yersinia pseudotuberculosis and Y. enterocolitica ...
 062. rosiglitazone - EPARs for authorised medicinal pro...
 061. Eptifibatide - EPARs for authorised medicinal prod...
 060. Zoledronic acid - EPARs for authorised medicinal p...
 059. Trastuzumab - EPARs for authorised medicinal produ...
 058. Potential for Tick-borne Bartonelloses | CDC EID
 057. Bartonella spp. and Ticks | CDC EID
 056. The Office on Women's Health Presents the Latest i...
 055. The Office on Women's Health Presents the Latest i...
 054. Split influenza virus, inactivated, containing ant...
 053. Etanercept - EPARs for authorised medicinal produc...
 052. Brote de leptospirosis ya causó seis muertes
 051. Exposures to Agents in BSL-3 and BSL-4 | CDC EID
 050. WNV and American White Pelicans | CDC EID
 049. Chikungunya Virus during Pregnancy | CDC EID
 048. Cost Analysis of WNV Outbreak | CDC EID
 047. Rare H3N2 Variants | CDC EID
 046. Infection of Squirrel Monkeys with Nipah Virus | C...
 045. Banna Virus, China | CDC EID
 044. Bluetongue Virus in Red Deer | CDC EID
 043. Tick-borne Encephalitis, Slovakia | CDC EID
 042. Rabies and Postexposure Prophylaxis | CDC EID
 041. Pandemic (H1N1) 2009 Virus in Domestic Cat | CDC E...
 040. School Closure and Pandemic (H1N1) 2009, Hong Kong...
 039. Putative New Lineage of West Nile Virus, Spain | C...
 038. VEE and Human Deaths | CDC EID
 037. PARV4-like Virus in Blood Products | CDC EID
 036. Measles Outbreak, the Netherlands, 2008 | CDC EID
 035. Neurologic Manifestations of Pandemic (H1N1) 2009 ...
 034. Transmission of West Nile Virus during Horse Autop...
 033. Breeding Sites of Bluetongue Virus Vectors, Belgiu...
 032. Two Lineages of Dengue Virus Type 2, Brazil | CDC ...
 031. Human Herpesvirus 8, Southern Siberia | CDC EID
 030. Medication Guides by FDA
 029. 2010 Biological License Application Approvals
 028. U.S. Preventive Services Task Force: Opportunity f...
 027. Comment Key Questions - AHRQ Effective Health Care...
 026. Human normal immunoglobulin (IVIg) - EPARs for hum...
 025. ACIP Provisional Recommendations for the Use of In...
 024. Survey Shows Gains in Food-Label Use, Health/Diet ...
 023. Navigating the Health Care System: Comparing Blood...
 022. European Medicines Agency - Human Medicines - Medi...
 021. Serologic Markers for Detecting Malaria in Areas o...
 020. Quinine-Resistant Malaria in Traveler Returning fr...
 019. Increasing Skin Infections and Staphylococcus aure...
 018. Global Origin of Mycobacterium tuberculosis in the...
 017. Extensively Drug-Resistant Mycobacterium tuberculo...
 016. Characterization and Qualification of Cell Substra...
 015. DROGAS HUÉRFANAS: Nuevas designaciones Enero y Feb...
 014. The Nikolas Symposium and Research
 013. Las enfermedades raras han de tomarse en serio (EN...
 012. VI Conferencia Internacional sobre Enfermedades Ra...
 011. New AHRQ Evidence Report on Lactose Intolerance an...
 010. New AHRQ Evidence Report on Colorectal Cancer Scre...
 009. AHRQ News and Numbers - February 26, 2010, Issue #...
 008. Hospital-Based Ambulatory Surgery, 2007 - AHRQ HCU...
 007. Guideline 113: Diagnosis and pharmacological manag...
 006. Guideline 115: Management of obesity
 005. Guideline 114: Non-pharmaceutical management of de...
 004. SCREENING FOR AND MANAGEMENT OF CHLAMYDIAL INFECTI...
 003. Improving the diagnosis and treatment of smear-neg...
 002. Respiratory tract infections - antibiotic prescrib...
 001. Coeliac disease. Recognition and assessment of coe...
 000. Lipid modification. Cardiovascular risk assessment...
 00i. Type 2 diabetes. The management of type 2 diabetes...
 0ii. Clinical practice guidelines for the diagnosis and...
 iii. Guidelines on TaT1 (non-muscle invasive) bladder c...
 00x. Guidelines for the use of antiretroviral agents in...
 0xx. Comprehensive evidence-based guidelines for interv...
 xxx. Clinical policy: critical issues in the management...
 00y. IntraMed - Artículos - ¿Cuál es su diagnóstico XII...
 0yy. e- Boletín DROGAS Y MEDICAMENTOS // Año Nº I - Nº ...
o ► febrero (345)
o ► enero (510)
• ► 2009 (4504)